Network Medicine

Network medicine is the application of network science to human disease, treating illness not as the failure of individual genes or proteins but as the perturbation of cellular interaction networks. The field was developed primarily by Albert-László Barabási and his collaborators, who proposed that diseases can be mapped onto localized subgraphs — disease modules — within the larger human interactome.

The central claim is structural: if two disease genes interact directly or through a short path in the protein-protein interaction network, the corresponding diseases are likely to share phenotypes, comorbidities, or drug sensitivities. This reframing has shifted pharmaceutical research toward polypharmacology and network-targeted therapies, though clinical translation remains slower than the topological predictions would suggest. The gap between network topology and therapeutic efficacy is one of the field's unresolved tensions.